Chemcrux Enterprises

₹245.5 -0.3 | 0.1%

WEBSITE BSE:540395 NSE : CHEMCRUX 18 May, 12:50

Market Cap ₹364 Cr.

Stock P/E 43.1

P/B 5

Current Price ₹245.5

Book Value ₹ 48.8

Face Value 10

52W High ₹359

Dividend Yield 0.41%

52W Low ₹ 242.1

Edit Ratio

Chemcrux Enterprises Research see more...

Overview Inc. Year: 1996Industry: Chemicals

Chemcrux Enterprises Ltd is a manufacturer of intermediates for bulk capsules, and dyes and pigments. The Company's merchandise encompass 2 Chloro Benzoic Acid; 3 Chloro Benzoic Acid; 4 Chloro 3 Nitro Benzoic Acid; 2 Chloro 5 Nitro Benzoic Acid; 4 Chloro Benzoic Acid; 4 Nitro Benzoic Acid; 2,4 Dichloro Benzoic Acid; Meta Nitro Benzoic Acid; Lassamide, and Meta Chloro Per Benzoic Acid. The Company also offers diverse products on custom necessities, which include Aceturic Acid; Meta Chloro Benzoyl Chloride; 3-Nitro-4-Methoxy Benzoic Acid; 2 Amino 5 Sulfonamide Benzoic Acid; 3,4 Dichloro Benzoic Acid; 5-Nitro Salycylic Acid, and 4-Chloro Benzoic Acid -3-Sulfonamide. The Company's plant has a capability of 120 metric tons per month. It exports to the Middle East, East Africa, Europe, and Japan. It is engaged in development and execution of numerous procedures, inclusive of High Pressure Oxidation, Nitration and Chloro Sulfonation.

Chemcrux Enterprises Share Price

New

Volume

Price

Price: NSE50 DMA200 DMAVolume

Quarterly Price

Quarterly Monthly

Show Value Show %

Peer Comparison

Chemcrux Enterprises Quarterly Results

#(Fig in Cr.)	Mar 2023	Mar 2024
Net Sales	20	19
Other Income	0	0
Total Income	20	19
Total Expenditure	15	16
Operating Profit	5	3
Interest	0	0
Depreciation	1	1
Exceptional Income / Expenses	0	0
Profit Before Tax	4	2
Provision for Tax	1	0
Profit After Tax	3	2
Adjustments	0	0
Profit After Adjustments	3	2
Adjusted Earnings Per Share	2	1.5

Chemcrux Enterprises Profit & Loss

#(Fig in Cr.)	Mar 2022	Mar 2023	TTM
Net Sales	95	95	39
Other Income	1	1	0
Total Income	96	96	39
Total Expenditure	75	74	31
Operating Profit	22	23	8
Interest	0	1	0
Depreciation	2	2	2
Exceptional Income / Expenses	0	0	0
Profit Before Tax	20	20	6
Provision for Tax	5	5	1
Profit After Tax	15	14	5
Adjustments	0	0	0
Profit After Adjustments	15	14	5
Adjusted Earnings Per Share	10	9.7	3.5

Growth Rates

#	1 Year	3 Year	5 Year	10 Year
Sales CAGR	0%	0%	0%	0%
Operating Profit CAGR	5%	0%	0%	0%
PAT CAGR	-7%	0%	0%	0%

#	1 Year	3 Year	5 Year	10 Year
Share Price CAGR	-29%	36%	53%	NA%
ROE Average	24%	25%	25%	25%
ROCE Average	28%	30%	30%	30%

Chemcrux Enterprises Balance Sheet

#(Fig in Cr.)	Mar 2022	Mar 2023
Shareholder's Funds	55	66
Minority's Interest	0	0
Borrowings	1	12
Other Non-Current Liabilities	2	3
Total Current Liabilities	26	18
Total Liabilities	84	99
Fixed Assets	25	34
Other Non-Current Assets	4	7
Total Current Assets	55	59
Total Assets	84	99

Chemcrux Enterprises Cash Flow

#(Fig in Cr.)	Mar 2022	Mar 2023
Opening Cash & Cash Equivalents	3	12
Cash Flow from Operating Activities	9	15
Cash Flow from Investing Activities	-3	2
Cash Flow from Financing Activities	4	3
Net Cash Inflow / Outflow	10	19
Closing Cash & Cash Equivalent	13	31

Chemcrux Enterprises Ratios

#	Mar 2022	Mar 2023
Earnings Per Share (Rs)	10.03	9.7
CEPS(Rs)	11.11	11.07
DPS(Rs)	2	2
Book NAV/Share(Rs)	36.88	44.84
Core EBITDA Margin(%)	21.73	22.54
EBIT Margin(%)	21.11	21.51
Pre Tax Margin(%)	20.94	20.65
PAT Margin (%)	15.6	15.09
Cash Profit Margin (%)	17.26	17.23
ROA(%)	17.74	15.71
ROE(%)	27.2	23.73
ROCE(%)	31.79	28.2
Receivable days	72.32	61.98
Inventory Days	44.33	49.22
Payable days	92.56	87.58
PER(x)	15.25	30.64
Price/Book(x)	4.15	6.62
Dividend Yield(%)	1.31	0.67
EV/Net Sales(x)	2.34	4.71
EV/Core EBITDA(x)	10.29	19.92
Net Sales Growth(%)	0	-0.12
EBIT Growth(%)	0	1.74
PAT Growth(%)	0	-3.37
EPS Growth(%)	0	-3.37
Debt/Equity(x)	0.16	0.23
Current Ratio(x)	2.1	3.34
Quick Ratio(x)	1.65	2.54
Interest Cover(x)	120.24	25.01
Total Debt/Mcap(x)	0.04	0.04

Chemcrux Enterprises Shareholding Pattern

#	Sep 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	72.94	72.94	72.94	72.94	72.94	72.94	72.94	72.92	72.92	72.92
FII	0	0	0	0	0	0	0	0	0	0
DII	0	0	0	0	0	0	0	0	0	0
Public	27.06	27.06	27.06	27.06	27.06	27.06	27.06	27.08	27.08	27.08
Others	0	0	0	0	0	0	0	0	0	0
Total	100	100	100	100	100	100	100	100	100	100

#	Sep 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	1.08	1.08	1.08	1.08	1.08	1.08	1.08	1.08	1.08	1.08
FII	0	0	0	0	0	0	0	0	0	0
DII	0	0	0	0	0	0	0	0	0	0
Public	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4
Others	0	0	0	0	0	0	0	0	0	0
Total	1.48	1.48	1.48	1.48	1.48	1.48	1.48	1.48	1.48	1.48

Pros

Company has a good return on equity (ROE) track record: 3 Years ROE 25%
Debtor days have improved from 92.56 to 87.58days.
Company is almost debt free.

Cons

Stock is trading at 5 times its book value.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.